{
    "clinical_study": {
        "@rank": "137937", 
        "arm_group": [
            {
                "arm_group_label": "DF-cereals", 
                "arm_group_type": "Experimental", 
                "description": "dietary fiber-enriched cereals is provided with 300mL of milk, total 3 times (day 1: 6 p.m. and 10 p.m., day 2: 8 a.m.)\namount of cereals: 79g for dinner and breakfast, 38.5g for night snack (10 p.m.)\none serving (40g) of steamed egg is added for dinner and breakfast"
            }, 
            {
                "arm_group_label": "white bread", 
                "arm_group_type": "Other", 
                "description": "white bread and strawberry jam is provided with 300mL of milk, total 3 times (day 1: 6 p.m. and 10 p.m., day 2: 8 a.m.)\namount of bread: 76g (2 slices) for dinner and breakfast, 38g (1 slice) for night snack (10 p.m.)\namount of strawberry jam: 40g for dinner and breakfast, 20g for night snack (10 p.m.)\none serving (40g) of steamed egg is added for dinner and breakfast"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to assess whether dietary fiber-enriched cereals effect on\n      postprandial glucose levels and plasma glucagon-like peptide 1 (GLP-1) and/or\n      glucose-dependent insulinotropic polypeptide (GIP) concentration in patients with type 2\n      diabetes mellitus."
        }, 
        "brief_title": "The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut Hormones", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "detailed_description": {
            "textblock": "Fifteen subjects with type 2 diabetes mellitus will be provided with study meals based on\n      either dietary fiber-enriched cereals or dietary fiber-poor white bread upon two separate\n      admissions in a cross-over fashion. The study meals will be provided at 6 p.m. and 10 p.m.\n      on the day of admission, and 8 a.m. on the next day. A mixed meal other than the study meals\n      will be given for lunch at noon on the second day. Blood sampling will be done every 30\n      minutes from 8 a.m. to 4 p.m. on the second day. The plasma levels of glucose, GLP-1, GIP,\n      insulin, glucagon, and free fatty acid will be measured."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  type 2 diabetes mellitus for > 6 months\n\n          -  HbA1c 6.5~8.4%\n\n          -  drug-naive or metformin monotherapy\n\n        Exclusion Criteria:\n\n          -  history of insulin therapy\n\n          -  allergy to wheat, flour, other cereals or nuts\n\n          -  lactose intolerance\n\n          -  history of hypoglycemic event (plasma glucose level < 70 mg/dL)\n\n          -  pregnancy / lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997281", 
            "org_study_id": "H-1307-133-508", 
            "secondary_id": "0620132990"
        }, 
        "intervention": [
            {
                "arm_group_label": "DF-cereals", 
                "description": "provided with 300mL of milk, total 3 times (day 1: 6 p.m. and 10 p.m., day 2: 8 a.m.)\namount: 79g for dinner and breakfast, 38.5g for night snack (10 p.m.)\none serving of steamed egg is added for dinner and breakfast", 
                "intervention_name": "dietary fiber-enriched cereals", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "white bread", 
                "description": "provided with strawberry jam (20g for night snack, otherwise 40g) and milk (300mL), total 3 times (day 1: 6 p.m. and 10 p.m., day 2: 8 a.m.)\namount: 76g (2 slices) for dinner and breakfast, 38g (1 slice) for night snack (10 p.m.)\none serving (40g) of steamed egg is added for dinner and breakfast", 
                "intervention_name": "white bread", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "dietary fiber", 
            "diabetes mellitus", 
            "gut hormone"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "email": "ymchomd@snu.ac.kr", 
                "last_name": "Young Min Cho, MD, PHD", 
                "phone": "82-2-2072-1965"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut Hormones", 
        "overall_contact": {
            "email": "ymchomd@snu.ac.kr", 
            "last_name": "Young Min Cho, MD, PHD", 
            "phone": "82-2-2072-1965"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University College of Medicine", 
            "last_name": "Young Min Cho, MD, PHD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Area under the curve (AUC) of plasma total GLP-1 levels after intake of the study meal", 
            "safety_issue": "No", 
            "time_frame": "every 30 minutes from 8 a.m. to noon on the second day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997281"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "AUC of plasma total GIP levels after intake of the study meal", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from 8 a.m. to noon on the second day"
            }, 
            {
                "measure": "AUC of plasma glucose levels after intake of the study meal", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from 8 a.m. to noon on the second day"
            }, 
            {
                "measure": "AUC of plasma insulin levels after intake of the study meal", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from 8 a.m. to noon on the second day"
            }, 
            {
                "measure": "AUC of plasma glucagon levels after intake of the study meal", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from 8 a.m. to noon on the second day"
            }, 
            {
                "measure": "AUC of serum free fatty acid levels after intake of the study meal", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from 8 a.m. to noon on the second day"
            }, 
            {
                "measure": "AUC of plasma total GIP levels after lunch", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from noon to 4 p.m. on the second day"
            }, 
            {
                "measure": "AUC of plasma glucose levels after lunch", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from noon to 4 p.m. on the second day"
            }, 
            {
                "measure": "AUC of plasma insulin levels after lunch", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from noon to 4 p.m. on the second day"
            }, 
            {
                "measure": "AUC of plasma glucagon levels after lunch", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from noon to 4 p.m. on the second day"
            }, 
            {
                "measure": "AUC of serum free fatty acid levels after lunch", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from noon to 4 p.m. on the second day"
            }, 
            {
                "measure": "AUC of plasma total GLP-1 levels after lunch", 
                "safety_issue": "No", 
                "time_frame": "every 30 minutes from noon to 4 p.m. on the second day"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}